ConductScience.org, home

Gene · 2658

GDF2: growth differentiation factor 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. GDF2: growth differentiation factor 2. Genes, record 2658. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2658

On this page

Gene

Symbol
GDF2
HGNC
Name
growth differentiation factor 2
HGNC
NCBI Gene ID
2658
NCBI Gene
HGNC ID
HGNC:4217
HGNC
Ensembl
ENSG00000263761
NCBI Gene
Aliases
BMP-9, BMP9, HHT5
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9UK05Growth/differentiation factor 242920Ensembl, GeneID, HGNC

Source UniProt

Patents507

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4705273 A22026-03-11178Q9UK05Espacenet
JP 2026004568 A2026-01-1448318Q9UK05Espacenet
EP 4650780 A22025-11-1917472Q9UK05Espacenet
JP 2025147176 A2025-10-065852Q9UK05Espacenet
JP 2025529142 A2025-09-046474Q9UK05Espacenet
US 12371689 B22025-07-296474Q9UK05Espacenet
JP 2025518726 A2025-06-1978Q9UK05Espacenet
JP 2025517970 A2025-06-1217472Q9UK05Espacenet
JP 2025028160 A2025-02-285852Q9UK05Espacenet
JP 2025013347 A2025-01-24178Q9UK05Espacenet

1 to 10 of 507

See all 507 patents

Drugs1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismAction
DALANTERCEPTCHEMBL2109662Growth/differentiation factor 2 inhibitorINHIBITOR

Source ChEMBL

Trials6

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT02024087DALANTERCEPTPHASE1/PHASE22020-12-22ClinicalTrials.gov
NCT01727336DALANTERCEPTPHASE22021-05-24ClinicalTrials.gov
NCT01720173DALANTERCEPTPHASE22017-12-08ClinicalTrials.gov
NCT01642082DALANTERCEPTPHASE22016-02-05ClinicalTrials.gov
NCT01458392DALANTERCEPTPHASE22017-06-27ClinicalTrials.gov
NCT00996957DALANTERCEPTPHASE1ClinicalTrials.gov

NIH grants1,035

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleGDF2 papersNewest fiscal year
P30CA014599Cancer Center Support Grant192025
UL1TR001863Yale Clinical and Translational Science Award92025
P30CA008748Cancer Center Support Grant82025
R01HL081397Mechanism of Matrix Gla Protein (MGP); Adipose Fibrosis82025
P30CA054174Mays Cancer Center at UT Health SA72025
R01NS079353BMP and Notch crosstalk in cerebral arteriovenous malformations62025
R01HL124021An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH52025
R01HL125811Slit2-ROBO signaling in pericytes and myeloid cells controls vascular development and ocular neovascular disease52025
P30CA016672Cancer Center Support Grant42025
R01DE030480Multi-Tissue Craniofacial Engineering using 3D-BMP9-Notch-Synergized Graphene Citrate Composite Scaffolds42025

1 to 10 of 1,035Source NIH's project files

See all 1,035 nih grants

Papers2,215

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Shared genetic architecture of schizophrenia and lupus identifies pleiotropic loci with distinct downstream mechanisms.Hum Mol Genet202642822865PubTator, text miningPubMed
3D-Printed DOX-LF-Loaded PLGA Biphasic Composite Scaffold Modulates Macrophage Polarization and Enhances Osteogenic-Angiogenic Regenerative Potential for Periodontitis.Front Biosci (Landmark Ed)202642811969PubTator, text miningPubMed
Circulating angiogenic and inflammatory biomarkers profiling in patients with hereditary hemorrhagic telangiectasia.Eur J Intern Med202642778431PubTator, text miningPubMed
Extracellular matrix remodeling and internal elastic lamina alterations in cerebral arteriovenous malformations: Insights into vascular wall biology.Neurosurg Rev202642749821PubTator, text miningPubMed
Screening of key genes in infectious ARDS and development of a disease risk prediction model.SAGE Open Med202642643537PubTator, text miningPubMed
Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets.Med Clin (Barc)202642628280PubTator, text miningPubMed
Targeting KIT prevents brain arteriovenous malformations driven by ALK1-deficient angiogenic endothelial cells.J Clin Invest202642579368PubTator, text miningPubMed
Demographic Factors Affect the BMAC Proteome.J Proteome Res202642565727PubTator, text miningPubMed
Association of serum BMP2 with delayed memory impairment in first-episode, drug-naïve schizophrenia.BMC Psychiatry202642469742PubTator, text miningPubMed
Targeting stiffness-dependent YAP/TAZ restores angiogenesis dynamics impaired by ALK1 knockout in silico.PLoS Comput Biol202642461962PubTator, text miningPubMed

1 to 10 of 2,215

See all 2,215 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2658

GET https://conductscience.org/api/genes/v1/2658/patents?page=2